Major Investor Increases Stake in Processa Pharmaceuticals with $200K Purchase

summarizeSummary

A 10% owner, The Chiliz Group Ltd, invested an additional $200,000 in Processa Pharmaceuticals, increasing its beneficial ownership to 13.0% of outstanding shares.

check_boxKey Events

• Significant Share Purchase

  The Chiliz Group Ltd (formerly HX Entertainment Ltd) acquired 86,956 shares of common stock for $200,000 on February 13, 2026.

• Increased Ownership Stake

  This purchase increases The Chiliz Group's beneficial ownership to 305,644 shares, representing 13.0% of Processa Pharmaceuticals' outstanding common stock.

• Investment at Premium to Current Market

  The shares were acquired at $2.30 per share, which was above the current market price of $2.0867 and near the 52-week low at the time of the transaction, indicating investor conviction.

auto_awesomeAnalysis

The Chiliz Group Ltd, a significant 10% owner, increased its stake in Processa Pharmaceuticals by purchasing an additional 86,956 shares for $200,000. This transaction, executed at $2.30 per share on February 13, 2026, demonstrates continued confidence in the company, especially as the purchase price was above the stock's current trading level and near its 52-week low at the time of the transaction. This follows a previous substantial investment in August 2025 and reinforces the investor's strategic interest, despite the recent news on February 19, 2026, regarding the expiration of a binding term sheet for PCS12852.